failure to respond or late response
on 26 Aug 2023
Last Applicant/ Owned by
300 Brickstone Square
Andover
MA
01810
Serial Number
97412097 filed on 16th May 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services business consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies Read More
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
business consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations
No 97412097
No Service Mark
No 1500.403.33
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Aug 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
26th Aug 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
26th Aug 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
18th Apr 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
18th Apr 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
10th Feb 2023 | FINAL REFUSAL WRITTEN |
10th Feb 2023 | FINAL REFUSAL E-MAILED |
10th Feb 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
26th Jan 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
25th Jan 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |